由于效力可能降低、心脏病发作和中风风险增加,超过141 000个通用阿托尔瓦斯特林片片被召回。 Over 141,000 generic atorvastatin tablets recalled due to potential reduced effectiveness, increasing heart attack and stroke risk.

超过141 000瓶普通阿托尔瓦斯特丹钙片(美国最处方的药)因溶解测试失败被召回, 这意味着它们可能无法在身体上正确分解, 降低了降低胆固醇的效力。 Over 141,000 bottles of generic atorvastatin calcium tablets, the most prescribed drug in the U.S., are being recalled due to failed dissolution testing, meaning they may not break down properly in the body, reducing effectiveness in lowering cholesterol. 由Ascend Laboratories于2025年9月发起并于10月升级为二级的召回行动影响到印度Alkem Laboratories制作的10毫克、20毫克、40毫克和80毫克药片。 The recall, initiated by Ascend Laboratories in September 2025 and upgraded to Class II in October, affects 10mg, 20mg, 40mg, and 80mg tablets made by Alkem Laboratories in India. 美国食品和药物管理局表示, 这种问题可能会增加长期心脏病发作和中风的风险, The FDA says the issue may increase long-term heart attack and stroke risks, but serious harm is unlikely. 病人不应在不咨询保健提供者的情况下停止服药,并可以检查“MFG Ascend”或“MFR Ascend”的标签,或核实NDC的号码。 Patients should not stop taking the medication without consulting a healthcare provider and can check labels for “MFG Ascend” or “MFR Ascend” or verify the NDC number. 药店可以提供替代药品。 Pharmacies can provide replacements.